Japanese Clinical Practice Guideline for Diabetes 2019.
作者信息
Araki Eiichi, Goto Atsushi, Kondo Tatsuya, Noda Mitsuhiko, Noto Hiroshi, Origasa Hideki, Osawa Haruhiko, Taguchi Akihiko, Tanizawa Yukio, Tobe Kazuyuki, Yoshioka Narihito
机构信息
Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Japan.
出版信息
Diabetol Int. 2020 Jul 24;11(3):165-223. doi: 10.1007/s13340-020-00439-5. eCollection 2020 Jul.
Abstract
摘要
相似文献
1
Japanese Clinical Practice Guideline for Diabetes 2019.《2019年日本糖尿病临床实践指南》
Diabetol Int. 2020 Jul 24;11(3):165-223. doi: 10.1007/s13340-020-00439-5. eCollection 2020 Jul.
2
3
Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version.日本胃肠道间质瘤（GIST）临床实践指南：英文版
Int J Clin Oncol. 2008 Oct;13(5):416-30. doi: 10.1007/s10147-008-0798-7. Epub 2008 Oct 23.
4
Japanese Clinical Practice Guideline for Diabetes 2019.《2019年日本糖尿病临床实践指南》
J Diabetes Investig. 2020 Jul;11(4):1020-1076. doi: 10.1111/jdi.13306.
5
Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology.骨转移的诊断与治疗：日本临床肿瘤学会、日本骨科学会、日本泌尿外科学会及日本放射肿瘤学会综合指南
ESMO Open. 2016 Mar 16;1(2):e000037. doi: 10.1136/esmoopen-2016-000037. eCollection 2016.
6
Japanese Clinical Practice Guideline for Diabetes 2016.《2016年日本糖尿病临床实践指南》
J Diabetes Investig. 2018 Mar 26;9(3):657-97. doi: 10.1111/jdi.12810.
7
Japanese Clinical Practice Guideline for Diabetes 2016.《2016年日本糖尿病临床实践指南》
Diabetol Int. 2018 Mar 27;9(1):1-45. doi: 10.1007/s13340-018-0345-3. eCollection 2018 Feb.
8
[Japanese Society of Hematology conflict of interest management in medical research].[日本血液学会医学研究中的利益冲突管理]
Rinsho Ketsueki. 2018;59(10):2390-2395. doi: 10.11406/rinketsu.59.2390.
9
ARDS Clinical Practice Guideline 2021.《2021年急性呼吸窘迫综合征临床实践指南》
J Intensive Care. 2022 Jul 8;10(1):32. doi: 10.1186/s40560-022-00615-6.
10
Formulation of Japanese Orthopaedic Association (JOA) clinical practice guideline for the management of low back pain- the revised 2019 edition.日本骨科协会（JOA）下腰痛管理临床实践指南的制定——2019 年修订版。
J Orthop Sci. 2022 Jan;27(1):3-30. doi: 10.1016/j.jos.2021.06.024. Epub 2021 Nov 23.
引用本文的文献
1
Hypoglycemia-Related Hospitalization in Adults with Type 2 Diabetes Receiving Insulin in Japan: Real-World Analysis Using the Medical Data Vision Database.日本接受胰岛素治疗的2型糖尿病成人患者低血糖相关住院情况：使用医学数据视觉数据库的真实世界分析
Diabetes Ther. 2025 Aug 28. doi: 10.1007/s13300-025-01776-x.
2
Sex and Age-specific Association between Isokinetic Knee Extensor Muscle Strength and Diabetes Mellitus: A Cross-sectional Study from the Sports Program Service Study.等速膝关节伸肌力量与糖尿病之间的性别和年龄特异性关联：一项来自体育项目服务研究的横断面研究
JMA J. 2025 Jul 15;8(3):789-798. doi: 10.31662/jmaj.2025-0111. Epub 2025 Jul 2.
3
Systematic Review of Nutritional Guidelines for the Management of Gestational Diabetes Mellitus: A Global Comparison.妊娠期糖尿病管理营养指南的系统评价：全球比较
Nutrients. 2025 Jul 18;17(14):2356. doi: 10.3390/nu17142356.
4
Mediators of the Association Between Severity of Noncommunicable Diseases and Subjective Health-Related Quality of Life.非传染性疾病严重程度与主观健康相关生活质量之间关联的介导因素。
Neuropsychopharmacol Rep. 2025 Sep;45(3):e70040. doi: 10.1002/npr2.70040.
5
Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational Study.蛋白尿和肾功能不全对2型糖尿病患者中SGLT2抑制剂改善贫血作用的影响：一项真实世界观察性研究
J Diabetes Res. 2025 Jun 28;2025:5399360. doi: 10.1155/jdr/5399360. eCollection 2025.
6
Optimal foot skin care for diabetes-related foot ulcer prevention: scoping review.预防糖尿病相关足部溃疡的最佳足部皮肤护理：范围综述
Diabetol Int. 2025 Mar 27;16(3):520-527. doi: 10.1007/s13340-025-00814-0. eCollection 2025 Jul.
7
The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes.衰弱对身体成分的影响及其对老年糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂的影响。
Metabolites. 2025 Jun 9;15(6):381. doi: 10.3390/metabo15060381.
8
Reciprocal Fluctuations in Lipoprotein Lipase, Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1, and Hepatic Triglyceride Lipase Levels in the Peripheral Bloodstream Are Correlated with Insulin Resistance.外周血中脂蛋白脂肪酶、糖基磷脂酰肌醇锚定高密度脂蛋白结合蛋白1和肝甘油三酯脂肪酶水平的相互波动与胰岛素抵抗相关。
Nutrients. 2025 May 30;17(11):1880. doi: 10.3390/nu17111880.
9
Within- and Between-Individual Variations in Protein, Sodium, Potassium, and Phosphorus Intake Estimated from Urinary Biomarkers and Dietary Records in Individuals with Type 2 Diabetes Mellitus.根据2型糖尿病患者的尿生物标志物和饮食记录估算的蛋白质、钠、钾和磷摄入量的个体内及个体间差异
Nutrients. 2025 May 22;17(11):1757. doi: 10.3390/nu17111757.
10
Effect of Intensified Multifactorial Treatments on Coronary Atherosclerosis in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus - Rationale and Design of the Randomized IMPACT-DM Trial.强化多因素治疗对冠心病合并2型糖尿病患者冠状动脉粥样硬化的影响——随机IMPACT-DM试验的原理与设计
Circ Rep. 2025 Apr 1;7(6):486-490. doi: 10.1253/circrep.CR-25-0021. eCollection 2025 Jun 10.
本文引用的文献
1
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).日本高血压学会高血压管理指南（JSH 2019）。
Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.
2
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.度拉糖肽与 2 型糖尿病患者的心血管结局（REWIND）：一项双盲、随机、安慰剂对照试验。
Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.
3
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.生活方式干预对糖耐量受损人群的发病率和死亡率的影响：大庆糖尿病预防结局研究 30 年的结果。
Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461. doi: 10.1016/S2213-8587(19)30093-2. Epub 2019 Apr 26.
4
Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report.日本糖尿病学会（JDS）/日本癌症协会（JCA）糖尿病与癌症联合委员会第二次报告
Diabetol Int. 2016 Mar 7;7(1):12-15. doi: 10.1007/s13340-016-0257-z. eCollection 2016 Mar.
5
14. Management of Diabetes in Pregnancy: .14. 妊娠期间糖尿病的管理： 。
Diabetes Care. 2019 Jan;42(Suppl 1):S165-S172. doi: 10.2337/dc19-S014.
6
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.利拉利汀对比安慰剂对伴有高心血管和肾脏风险的 2 型糖尿病成人患者主要心血管事件的影响：CARMELINA 随机临床试验。
JAMA. 2019 Jan 1;321(1):69-79. doi: 10.1001/jama.2018.18269.
7
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.依洛尤单抗与急性冠脉综合征后的心血管结局。
N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.
8
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2018 年美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）共识报告：2 型糖尿病患者高血糖管理。
Diabetes Care. 2018 Dec;41(12):2669-2701. doi: 10.2337/dci18-0033. Epub 2018 Oct 4.
9
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.高剂量与低剂量培伐他汀在日本稳定型冠状动脉疾病患者中的应用（REAL-CAD）：一项随机优势试验。
Circulation. 2018 May 8;137(19):1997-2009. doi: 10.1161/CIRCULATIONAHA.117.032615.
10
Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes.从儿童期到成年早期超重的变化与 2 型糖尿病风险。
N Engl J Med. 2018 Apr 5;378(14):1302-1312. doi: 10.1056/NEJMoa1713231.
Zotero 插件